• Search

Meet the Team

Axol Management Team

Jonathan Milner, PhD

Jonathan Milner, PhD

Chairman

Jonathan is an experienced entrepreneur and business leader with a background in genetic research. When he was doing his postdoctoral research at the University of Cambridge, he identified the market opportunity for supplying quality, data-rich antibody products to research communities. In 1998, Jonathan co-founded Abcam, and since then he has led the company from a start-up to become the global leader in the supply of protein research tools.


Liam Taylor

Liam Taylor

CEO

Liam has over 11 years’ C-level experience in both US listed and UK private equity environments, with an emphasis on the diagnostics, pharma and life science sectors, partnering with blue chip global organisations and start-ups alike. A true business leader, Liam spent 10 years with the BBI Group: initially as the Group CFO, before taking on the leadership of BBI Solutions as Managing Director in 2014. BBI Solutions is a leading expert in immunoassay development, biological reagents and manufacturing services. The business revenues more than doubled during his tenure, growing from £23m to over £52m, driven by solid organic growth and strategic acquisitions that built out product and service offerings to its global customer base. After leaving BBI Solutions, Liam worked as a consultant to start-ups in the diagnostics and biotech space, joining Axol Bioscience in July 2020.

Liam is a highly experienced CEO and Managing Director, with extensive knowledge of running commercial, operations, finance and innovations teams. His leadership approach is strongly influenced by his Australian heritage: based on openness, honesty and transparency. He thrives on leading businesses, as well as developing high performing teams and business cultures. Although not a scientist, he is passionate about science with a naturally inquisitive mind and personally aspires to improve end patient outcomes around the world.



Wayne Humphreys 

Chief Financial Officer

A professional Commercial Chief Financial Officer / Finance Director with over 30 years post qualification experience working in fast pace demanding business environments in manufacturing, engineering, sporting, service, and logistics sectors within the UK and overseas, with private equity/venture capital investors.

Strong on business analysis /improvements, cash and working capital management, cost reduction, strategic planning, budgeting, forecasting, management reporting, turnaround, change management, and acquisitions / disposals, delivering commercial “Value for Money” solutions.


Ashley Barnes 

Chief Science Officer

Ashley has latterly spent the last 4 Years at Censo Biotechnologies where as the Chief Scientific Officer he lead the strategy and scientific development of new and novel induced pluripotent stem cells. Coupled to this was the development of robust disease relevant assays including co-culture models for neuroscience and inflammation. for contract research for both Biotech and Pharma. Ashley has extensive experience in the pharma industry having been at GlaxoSmithKline for 25 years in leading teams in Neuroscience, Respiratory and Immunology disease areas for numerous drug discovery programme with technical competencies including molecular biology, gene editing, pharmacology, cell scale -up functional assay development .



Sonya Ansell 

Head of Human Resources

Sonya joined Axol in February 2021 as Head of Human Resources.

She has over 15 years generalist HR experience, 10 of which have been at a senior level, predominantly within the Pharmaceutical, Biotech sectors. She has a broad spectrum of experience within HR including employee relations, benefits, recruitment, policies, harmonization and integration of HR following acquisitions and mergers and the implementation of HR Systems (HRIS).